| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/13/1999 | EP0889892A1 Azaspiro derivatives |
| 01/13/1999 | EP0889891A1 4-[(thien-2-yl)methyl]imidazole derivatives having alpha2-adrenoceptor agonistic activity |
| 01/13/1999 | EP0889889A1 Piperazine and piperidine compounds |
| 01/13/1999 | EP0889888A1 Novel treatment for cns injuries |
| 01/13/1999 | EP0889887A1 Novel treatment for cns injuries |
| 01/13/1999 | EP0889731A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 01/13/1999 | EP0889730A1 Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation |
| 01/13/1999 | EP0889725A1 Method for treating bipolar disorder |
| 01/13/1999 | EP0789567A4 A method for treating vascular headaches |
| 01/13/1999 | EP0555327B1 Alkylidene analogs of 1'-aminospiro-[isoquinoline- 4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors in vivo |
| 01/13/1999 | CN1205010A Isoxazolidine derivatives |
| 01/13/1999 | CN1205009A Pyrazolopyrimidines type compound |
| 01/13/1999 | CN1205006A Substituted tetracyclic tetrahydrofuran derivatives |
| 01/12/1999 | US5859257 Isoxazole compounds as cyclooxygenase inhibitors |
| 01/12/1999 | US5859246 Treating neuropsychological disorders |
| 01/12/1999 | US5859244 1,4-dihydropyridine derivatives and methods of producing the same |
| 01/12/1999 | US5859229 For inhibition of gene expression of human cyclooxygenase 2 by binding to specific untranslated regions of messenger rna; treatment of premature labor, preeclampsia, endometriosis, rheumatoid arthritis |
| 01/12/1999 | US5859201 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/12/1999 | US5859191 Method for the site-specific modification of peptide alpha amines |
| 01/12/1999 | US5859046 Biologically active oreido derivatives useful in the treatment of multiple sclerosis |
| 01/12/1999 | US5859036 Antiinflammatory agents, analgesics |
| 01/12/1999 | US5859031 Small molecule inhibitors of rotamase enzyme activity |
| 01/12/1999 | US5859029 Heterocyclic compounds method of preparing them and pharmeutical compositions in which they are present |
| 01/12/1999 | US5859016 Treating dementia by administering acetylcholinesterase inhibitor |
| 01/12/1999 | US5859011 Dihydropyridine derivatives as bradykinin antagonist |
| 01/12/1999 | US5859004 Use of heterocyclic compounds for the treatment of conditions caused by malfunctioning of the nicotinic cholinergic system |
| 01/12/1999 | US5858999 Cosolvent parenteral formulation of tirilazad |
| 01/12/1999 | US5858980 Peptide fragments of myelin basic protein |
| 01/12/1999 | US5858716 H2CAA71 polynucleotides |
| 01/12/1999 | US5858708 For genetically engineered expression vectors in host cells, antisense molecules, and diagnosis and treatment of nervous system degenerative disorders such as amyotrophic lateral sclerosis |
| 01/12/1999 | US5858393 Transdermal patch comprising acrylic adhesive, muscarinic agonist; treating alzheimer*s disease, severe pain; reduced side effects |
| 01/12/1999 | US5858388 Matrix of ethylene-vinyl acetate copolymer, hydromorphone embedded homogeneously in matrix and biocompatible, non-biodegradable polymer coating |
| 01/12/1999 | US5858376 Introducing into cell isolated protein derived from herpes simplex virus |
| 01/08/1999 | CA2236468A1 Novel use |
| 01/07/1999 | WO1999000507A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 01/07/1999 | WO1999000500A1 Calcium-binding phosphoprotein |
| 01/07/1999 | WO1999000406A1 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 01/07/1999 | WO1999000391A1 Tricyclic pyrazolo-pyridazinone analogues as gaba-a receptor ligands |
| 01/07/1999 | WO1999000389A1 5-[(HETEROARYL)ALKYL]-3-OXO-PYRIDO[1,2-a]BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS |
| 01/07/1999 | WO1999000387A1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy |
| 01/07/1999 | WO1999000385A1 3-pyridyl-1-aza-bicyclo-alkane derivatives for prevention and treatment of cns disorders |
| 01/07/1999 | WO1999000384A1 New quinoxaline dione derivatives, the production thereof and use of the same in medicaments |
| 01/07/1999 | WO1999000368A1 Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents |
| 01/07/1999 | WO1999000353A1 Novel thyroid receptor ligands and method |
| 01/07/1999 | WO1999000346A1 Synthesis of dihydrohonokiol compositions |
| 01/07/1999 | WO1999000138A1 Methods and compounds for treating alzheimer's disease |
| 01/07/1999 | WO1999000133A1 Method for optimizing retinal and optic nerve health |
| 01/07/1999 | WO1999000131A1 Novel process for manufacturing paroxetine solid dispersions |
| 01/07/1999 | WO1999000119A1 Use of a specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing |
| 01/07/1999 | WO1999000116A2 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 01/07/1999 | WO1999000115A1 Use of antagonists or partial agonists of the vanilloid receptor complexes for treating neurodegenerative diseases |
| 01/07/1999 | WO1998054213A3 Neurotrophic factor receptors |
| 01/07/1999 | WO1998045427A3 Insulin-like growth factor agonist peptides |
| 01/07/1999 | WO1998039463A3 Lentivirus based vector and vector system |
| 01/07/1999 | WO1998035048A3 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 01/07/1999 | EP0889129A2 GidA1 polypeptides from Staphylococcus aureus |
| 01/07/1999 | EP0889127A1 Serine/threonine protein kinase (H-SGK2) |
| 01/07/1999 | EP0889126A2 YNL075W/HTXFT19 polypeptide |
| 01/07/1999 | EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase |
| 01/07/1999 | EP0889044A1 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazole-4-carboxamide (PBI) derivatives useful in treating central nervous system disorders |
| 01/07/1999 | EP0888772A1 Sustained-release metal valproate tablets |
| 01/07/1999 | EP0888374A1 High affinity nucleic acid ligands of complement system proteins |
| 01/07/1999 | EP0888358A1 Piperidine derivatives |
| 01/07/1999 | EP0888357A1 Azaspiro derivatives |
| 01/07/1999 | EP0888356A1 Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors |
| 01/07/1999 | EP0888355A1 Heterocyclic compounds and their preparation and use |
| 01/07/1999 | EP0888350A1 Azolobenzazepine derivatives as neurologically active agents |
| 01/07/1999 | EP0888340A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 01/07/1999 | EP0888337A1 Piperidone tachykinin antagonists |
| 01/07/1999 | EP0888335A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases |
| 01/07/1999 | EP0888327A1 Benzopyran derivatives having leukotriene-antagonistic action |
| 01/07/1999 | EP0888325A1 Novel cyclic amino acids as pharmaceutical agents |
| 01/07/1999 | EP0888324A1 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof |
| 01/07/1999 | EP0888323A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 01/07/1999 | EP0888320A1 Novel n-aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands |
| 01/07/1999 | EP0888319A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 01/07/1999 | EP0888313A1 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors |
| 01/07/1999 | EP0888309A1 Imidazole derivatives having affinity for alpha2 receptors activity |
| 01/07/1999 | EP0888289A1 Anticonvulsant enantiomeric amino acid derivatives |
| 01/07/1999 | EP0888286A1 Novel substituted cyclic amino acids as pharmaceutical agents |
| 01/07/1999 | EP0888285A1 Novel bridged cyclic amino acids as pharmaceutical agents |
| 01/07/1999 | EP0888114A1 USE OF (+)-$g(a)-(2,3-DIMETHOXYPHENYL)-1- 2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL IN TREATING DEPRESSIVE DISORDERS AND BIPOLAR DISORDERS |
| 01/07/1999 | EP0876818A4 Agent for treating neuro-degenerative disorders |
| 01/07/1999 | EP0592562B1 Bmp-9 compositions |
| 01/07/1999 | EP0386117B1 Treating premenstrual or late luteal phase syndrome |
| 01/07/1999 | DE19728436A1 Niedrigdosierte 15-Desoxyspergualin-Präparate Low-dose 15-deoxyspergualin preparations |
| 01/07/1999 | DE19728326A1 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln New quinoxalinedione derivatives, their preparation and use in medicaments |
| 01/07/1999 | CA2297723A1 Synthesis of dihydrohonokiol compositions |
| 01/07/1999 | CA2295311A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 01/07/1999 | CA2295208A1 Calcium-binding phosphoprotein |
| 01/07/1999 | CA2295089A1 Use of antagonists or partial agonists of the vanilloid receptor complexes for treating neurodegenerative diseases |
| 01/07/1999 | CA2294343A1 Method for optimizing retinal and optic nerve health |
| 01/07/1999 | CA2294232A1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 01/07/1999 | CA2293565A1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy |
| 01/07/1999 | CA2291734A1 Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents |
| 01/07/1999 | CA2291689A1 Tricyclic pyrazolo-pyridazinone analogues as gaba-a receptor ligands |
| 01/06/1999 | CN1204320A Alpha-substituted arylsulphonamido hydroxamic acids as TNF-alpha and matrix metalloproteinase inhibitors |
| 01/06/1999 | CN1204316A O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same |
| 01/06/1999 | CN1204315A New phenylamidine derivatives process for preparing the same and their use as medicaments |
| 01/06/1999 | CN1204264A Production of analgesic synergy by co-administration of sub-analgesic doses of a mu opioid agonist and kappa-2 opioid agonist |